Journal article · 2024 · Open access
Cancer incidence and mortality in China, 2022
Journal of the National Cancer Center, 4(1), 47–53 · Published 1 February 2024 · DOI 10.1016/j.jncc.2024.01.006
In brief
“Cancer incidence and mortality in China, 2022” is a 2024 journal article by Bingfeng Han and 8 co-authors, published in Journal of the National Cancer Center. OpenAlex counts 3,040 citations as of 15 November 2026. It is open access under a CC BY-NC-ND licence: the full text is free to read at Journal of the National Cancer Center.
- Citations
- 3,040
- Most cited in
- 2025 (1,362)
- Field-weighted impact
- 488.73
- References
- 18
- Authors
- 9
Abstract
Background: The National Cancer Center (NCC) of China regularly reports the nationwide statistics on cancer incidence and mortality in China. The International Agency for Research on Cancer (IARC) calculates and publishes the cancer burden of countries around the world every two years. To ensure consistency between the actual surveillance data in China and the data published by IARC, NCC has received approval from the National Health Commission and IARC to simultaneously release the cancer burden data for China in GLOBOCAN 2022. Methods: There were a total of 700 registries reporting high-quality data on cancer incidence and mortality across China in 2018, of which 106 registries with continuous monitoring from 2010 to 2018 were used to establish an age-period-cohort model to simulate the trend of cancer incidence and mortality and to estimate the incidence and mortality in China in 2022. In addition, we analyzed the temporal trends of age-standardized cancer incidence and mortality from 2000 to 2018 using data from 22 continuous cancer registries. Results: It was estimated about 4,824,700 new cancer cases and 2,574,200 new cancer deaths occurred in China in 2022. Cancers of the lung, colon-rectum, thyroid, liver and stomach were the top five cancer types, accounting for 57.42% of new cancer cases. Cancers of the lung, liver, stomach, colon-rectum and esophagus were the five leading causes of cancer deaths, accounting for 67.50% of total cancer deaths. The crude rate and age-standardized incidence rate (ASIR) were 341.75 per 100,000 and 201.61 per 100,000, respectively. The crude mortality rate was 182.34 per 100,000 and the age-standardized mortality rate (ASMR) was 96.47 per 100,000. The ASIR of all cancers combined increased by approximately 1.4% per year during 2000-2018, while the ASMR decreased by approximately 1.3% per year. We observed decreasing trends in ASIR and ASMR for cancers of the esophagus, stomach, and liver, whereas the ASIR increased significantly for cancers of the thyroid, prostate, and cervix. Conclusions: Cancer remains a major public health concern in China, with a cancer profile that reflects the coexistence of developed and developing regions. Sustained implementation of prevention and control measures has resulted in significant reductions in the incidence and mortality rates of certain historically high incidence cancers, such as esophageal, stomach and liver cancers. Adherence to the guidelines of the Healthy China Action Plan and the Cancer Prevention and Control Action Plan, along with continued efforts in comprehensive risk factor control, cancer screening, early diagnosis and treatment, and standardization of diagnostic and therapeutic protocols, are key strategies to effectively mitigate the increasing cancer burden by…
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Han, B., Zheng, R., Zeng, H., Wang, S., Sun, K., Chen, R., Li, L., Wei, W., & He, J. (2024). Cancer incidence and mortality in China, 2022. Journal of the National Cancer Center, 4(1), 47–53. https://doi.org/10.1016/j.jncc.2024.01.006
MLA 9
Han, Bingfeng, et al. “Cancer incidence and mortality in China, 2022.” Journal of the National Cancer Center, vol. 4, no. 1, 2024, pp. 47–53. https://doi.org/10.1016/j.jncc.2024.01.006.
Chicago
Han, Bingfeng, Rongshou Zheng, Hongmei Zeng, Shaoming Wang, Kexin Sun, Ru Chen, Li Li, Wenqiang Wei, and Jie He. 2024. “Cancer incidence and mortality in China, 2022.” Journal of the National Cancer Center 4 (1): 47–53. https://doi.org/10.1016/j.jncc.2024.01.006.
Harvard
Han, B. et al. (2024) ‘Cancer incidence and mortality in China, 2022’, Journal of the National Cancer Center, 4(1), pp. 47–53. doi:10.1016/j.jncc.2024.01.006.
IEEE
B. Han et al., “Cancer incidence and mortality in China, 2022,” Journal of the National Cancer Center, vol. 4, no. 1, pp. 47–53, 2024, doi: 10.1016/j.jncc.2024.01.006.
BibTeX
@article{han2024cancer,
title = {{Cancer incidence and mortality in China, 2022}},
author = {Han, Bingfeng and Zheng, Rongshou and Zeng, Hongmei and Wang, Shaoming and Sun, Kexin and Chen, Ru and Li, Li and Wei, Wenqiang and He, Jie},
journal = {Journal of the National Cancer Center},
year = {2024},
volume = {4},
number = {1},
pages = {47--53},
doi = {10.1016/j.jncc.2024.01.006},
url = {https://doi.org/10.1016/j.jncc.2024.01.006}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2012 | 1 | |
| 2021 | 2 | |
| 2022 | 1 | |
| 2023 | 1 | |
| 2024 | 375 | |
| 2025 | 1,362 | |
| 2026 | 1,298 |
Its field-weighted citation impact is 488.73: it has been cited 488.73 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- cancer incidence
- cancer mortality
- cancer burden
- China
- GLOBOCAN 2022
- age-standardized incidence rate
- age-standardized mortality rates
- temporal trends
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Han, B., Zheng, R., Zeng, H., Wang, S., Sun, K., Chen, R., Li, L., Wei, W., & He, J. (2024). Cancer incidence and mortality in China, 2022. Journal of the National Cancer Center, 4(1), 47–53. https://doi.org/10.1016/j.jncc.2024.01.006
How many times has this paper been cited?
3,040 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access: read the free full text at Journal of the National Cancer Center.
Who wrote this paper?
Bingfeng Han, Rongshou Zheng, Hongmei Zeng, Shaoming Wang, Kexin Sun, Ru Chen, Li Li, Wenqiang Wei, Jie He.
What is the DOI of this paper?
10.1016/j.jncc.2024.01.006. The permanent link is https://doi.org/10.1016/j.jncc.2024.01.006.
Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.